Moat Ross bought KNSA
October 30, 2026 · Form 4 insider transaction
Moat Ross bought 3,760 shares of Kiniksa Pharmaceuticals International, plc at $11.97 per share, a transaction worth $45.0K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
3,760
Price
$11.97
Total value
$45.0K
InsiderMoat Ross
RoleOfficer
SecurityClass A Ordinary Share
Transaction codeM: Option exercise
Transaction dateOctober 30, 2026
Filing dateNovember 3, 2026
Shares owned after57,237
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on July 29, 2026.